AbbVie Inc. (ABBV) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
AbbVie Inc. (ABBV) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$41.64 BLiabilities(calculated)$141.00 BCurrent assets$33.67 BNon-current liabilities$99.36 BAssets$135.12 BNon-current assets$101.45 BEquity−$5.89 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSAccounts receivable, netPrepaid expenses and otherCash and equivalentsInventoriesIntangible assets, netGoodwillOther assetsProperty and equipment, netInvestmentsAccounts payable and accrued liabilitiesCurrent portion of long-term debtLong-term debtOther long-term liabilitiesDeferred income taxesAdditional paid-in capitalCommon stock, $0.01 par value, 4,000,000,000 shares authorized, 1,844,174,521 shares issued as of June 30, 2026 and 1,838,678,628 as of December 31, 2025Noncontrolling interestAccumulated deficitCommon stock held in treasury, at cost, 77,105,240 shares as of June 30, 2026 and 70,802,593 as of December 31, 2025Accumulated other comprehensive lossCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilities (calculated)EquityCurrent liabilitiesCurrent liabilities$41.64 BLiabilities (calculated)Liabilities(calculated)$141.00 BAccounts payable and accrued liabilitiesAccounts payable and accrued liabilities$33.30 BCurrent portion of long-term debtCurrent portion of long-term debt$8.34 BAccounts receivable, netAccounts receivable, net$13.82 BCurrent assetsCurrent assets$33.67 BPrepaid expenses and otherPrepaid expenses and other$8.15 BNon-current liabilitiesNon-current liabilities$99.36 BAssetsAssets$135.12 BLong-term debtLong-term debt$62.48 BCash and equivalentsCash and equivalents$6.57 BInventoriesInventories$5.13 BNon-current assetsNon-current assets$101.45 BOther long-term liabilitiesOther long-term liabilities$34.60 BIntangible assets, netIntangible assets, net$49.14 BDeferred income taxesDeferred income taxes$2.28 BGoodwillGoodwill$35.52 BAdditional paid-in capitalAdditional paid-in capital$23.16 BOther assetsOther assets$10.73 BCommon stock, $0.01 par value, 4,000,000,000 shares authorized, 1,844,174,521 shares issued as of June 30, 2026 and 1,838,678,628 as of December 31, 2025Common stock$18.00 MEquityEquity−$5.89 BProperty and equipment, netProperty and equipment, net$5.80 BNoncontrolling interestNoncontrolling interest$47.00 MInvestmentsInvestments$266.00 MAccumulated deficitAccumulated deficit−$17.33 BCommon stock held in treasury, at cost, 77,105,240 shares as of June 30, 2026 and 70,802,593 as of December 31, 2025Common stock held in treasury−$10.62 BAccumulated other comprehensive lossAccumulated other comprehensive loss−$1.16 B
Chart details

AbbVie Inc. (ABBV) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
135,115,000,000 US dollars
Current assets
33,669,000,000 US dollars
Non-current assets
101,446,000,000 US dollars
Liabilities (calculated)
141,003,000,000 US dollars
Current liabilities
41,642,000,000 US dollars
Non-current liabilities
99,361,000,000 US dollars
Equity
negative 5,888,000,000 US dollars
Noncontrolling interest
47,000,000 US dollars. Included in consolidated equity; this amount is not added again.
Accounts receivable, net
13,824,000,000 US dollars
Prepaid expenses and other
8,149,000,000 US dollars
Cash and equivalents
6,569,000,000 US dollars
Inventories
5,127,000,000 US dollars
Intangible assets, net
49,139,000,000 US dollars
Goodwill
35,519,000,000 US dollars
Other assets
10,726,000,000 US dollars
Property and equipment, net
5,796,000,000 US dollars
Investments
266,000,000 US dollars
Accounts payable and accrued liabilities
33,301,000,000 US dollars
Current portion of long-term debt
8,341,000,000 US dollars
Short-term borrowings
0 US dollars
Long-term debt
62,481,000,000 US dollars
Other long-term liabilities
34,603,000,000 US dollars
Deferred income taxes
2,277,000,000 US dollars
Additional paid-in capital
23,156,000,000 US dollars
Common stock, $0.01 par value, 4,000,000,000 shares authorized, 1,844,174,521 shares issued as of June 30, 2026 and 1,838,678,628 as of December 31, 2025
18,000,000 US dollars
Noncontrolling interest
47,000,000 US dollars
Accumulated deficit
negative 17,333,000,000 US dollars
Common stock held in treasury, at cost, 77,105,240 shares as of June 30, 2026 and 70,802,593 as of December 31, 2025
negative 10,618,000,000 US dollars
Accumulated other comprehensive loss
negative 1,158,000,000 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
AbbVie Inc. (ABBV) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!